ArticleCancer management and research2020

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A.

Cuiping Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.